[11C]Flumazenil Positron Emission Tomography Analyses of Brain Gamma-Aminobutyric Acid Type A Receptors in Angelman Syndrome

Journal of Pediatrics

Volumn 152, Issue 4, 2008, Pages

  Asahina, Naoko ^a   Shiga, Tohru ^a   Egawa, Kiyoshi ^a   Shiraishi, Hideaki ^a   Kohsaka, Shinobu ^a   Saitoh, Shinji ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; CARBON 11; CONTRAST MEDIUM; FLUMAZENIL; FLUMAZENIL C11; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE UBE3A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BINDING AFFINITY; BRAIN CORTEX; CEREBELLUM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE MUTATION; GENOTYPE; HAPPY PUPPET SYNDROME; HUMAN; IMAGE QUALITY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN FUNCTION;

EID: 40749110178     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2007.08.038     Document Type: Article

References (34)

1. Williams C.A., Beaudet A.L., Clayton-Smith J., Knoll J.H., Kyllerman M., Laan L.A., et al. Angelman syndrome 2005: updated consensus for diagnostic criteria. Am J Med Genet 140A (2006) 413-418
2. Rougeulle C., Glatt H., and Lalande M. The Angelman syndrome candidate gene, UBE3A/E6-AP, is imprinted in the brain. Nat Genet 17 (1997) 14-15
3. Saitoh S., Wada T., Okajima M., Takano K., Sudo A., and Niikawa N. Uniparental disomy and imprinting defects in Japanese patients with Angelman syndrome. Brain Dev 27 (2005) 389-391
4. Saitoh S., Harada N., Jinno Y., Hashimoto K., Imaizumi K., Kuroki Y., et al. Molecular and clinical study of 61 Angelman syndrome patients. Am J Med Genet 52 (1994) 158-163
5. Lossie A.C., Whitney M.M., Amidon D., Dong H.J., Chen P., Theriaque D., et al. Distinct phenotypes distinguish the molecular classes of Angelman syndrome. J Med Genet 38 (2001) 834-845
6. Moncla A., Malzac P., Volckel M.A., Auquier P., Girardot L., Mattei M.G., et al. Phenotype-genotype correlation in 20 deletion and 20 non-deletion Angelman syndrome patients. Eur J Hum Genet 7 (1999) 131-139
7. Homanics G.E., DeLorey T.M., Firestone L.L., Quinlan J.J., Handforth A., Harrison N.L., et al. Mice devoid of gamma-aminobutyrate type A receptor beta3 subunit have epilepsy, cleft palate, and hypersensitive behavior. Proc Natl Acad Sci U S A 94 (1997) 4143-4148
8. A receptor have the epilepsy phenotype and many behavioral characteristics of Angelman syndrome. J Neurosci 18 (1998) 8505-8514
9. Delorey T.M., and Olsen R.W. GABA and epileptogenisis: comparing gabrb3 gene-deficient mice with Angelman syndrome in man. Epilepsy Res 36 (1999) 123-132
10. A receptor alterations. Neurosci Lett 340 (2003) 205-208
11. Unwin N. Neurotransmitter action: opening of a ligand-gated channel. Neuron 10 Suppl (1993) 31-41
12. A receptor gene family: new targets for therapeutic intervention. Neurochem Int 34 (1999) 387-390
13. Hensch T.K. Critical period plasticity in local cortical circuits. Nat Rev Neurosci 6 (2005) 877-888
14. A receptor β3 subunit deletions. Ann Neurol 49 (2001) 110-113
15. Kuroda S., Shiga T., Ishikawa T., Houkin K., Narita T., Katoh C., et al. Reduced blood flow and preserved vasoreactivity characterize oxygen hypometabolism due to incomplete infarction in occlusive carotid artery diseases. J Nucl Med 45 (2004) 943-949
16. Shiga T., Ikoma K., Katoh C., Isoyama H., Matsuyama T., Kuge Y., et al. Loss of neuronal integrity: a case of hypometabolism in patients with traumatic brain injury without MRI abnormality in the chronic stage. Eur J Nucl Med Mol Imaging 33 (2006) 817-822
17. Lammertsma A.A., and Hume S.P. Simplified reference tissue model for PET receptor studies. Neuroimage 4 (1996) 153-158
18. Millet P., Graf C., Buck A., Walder B., and Ibanez V. Evaluation of the reference tissue models for PET and SPECT benzodiazepine binding parameters. Neuroimage 17 (2002) 928-942
19. Ardekani B.A., Braun M., Hutton B.F., Kanno I., and Iida H. A fully automatic multimodality image registration algorithm. J Comput Assist Tomogr 19 (1995) 615-623
20. Shiga T., Morita K., Takano A., Katoh C., Nakamura F., Tsukamoto E., et al. Clinical advantages of interictal SPECT coregistered to magnetic resonance imaging in patients with epilepsy. Clin Nucl Med 26 (2001) 334-339
21. Nishioka T., Shiga T., Shirato H., Tsukamoto E., Tsuchiya K., Kato T., et al. Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas. Int J Radiat Oncol Biol Phys 53 (2002) 1051-1057
22. A receptors measured with positron emission tomography. Ann Neurol 49 (2001) 618-626
23. Pratt G.D., Richter A., Mohler H., and Loscher W. Regionally selective and age-dependent alterations in benzodiazepine receptor binding in the genetically dystonic hamster. J Neurochem 64 (1995) 2153-2158
24. Fossouulaki A., Sarantopoulos C., and Papilas K. Flumazenil reduced the duration of thiopentone but not of propofol anaesthesia in humans. Can J Anaesth 40 (1993) 10-12
25. Adachi Y.U., Watanabe K., Higuchi H., and Satoh T. High-dose flumazenil potentiates the hypnotic activity of propofol, but not that of thiopental, in ddY mice. Acta Anaesthesiol Scand 45 (2001) 848-852
26. 11C]flumazenil and positron emission tomography. Epilepsia 36 (1995) 113-121
27. 11C]flumazenil positron emission tomography study. Epilepsia 38 (1997) 1089-1097
28. Rogawski M.A., and Porter R.J. Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol Rev 42 (1990) 223-286
29. Fritschy J.M., and Brunig I. Formation and plasticity of GABAergic synapses: physiological mechanisms and pathophysiological implications. Pharm Thera 98 (2003) 299-323
30. Represa A., and Ben-Ari Y. Trophic actions of GABA on neuronal development. Trends Neurosci 28 (2005) 278-283
31. Als H., Duffy F.H., MacAnulty G.B., Rivkin M.J., Vajapeyam S., Mulkern P.V., et al. Early experience alters brain function and structure. Pediatrics 113 (2004) 846-857
32. Brooks-Kayal A.M. Rearranging receptors. Epilepsia 46 Suppl 7 (2005) 29-38
33. A receptor cell surface number and subunit stability are regulated by the ubiquitin-like protein Plic-1. Nat Neurosci 4 (2001) 908-916
34. A receptors at synaptic sites. Brain Res Rev 39 (2002) 74-83